Legal final arguments in Vioxx trial

PHILADELPHIA (Reuters) - Lawyers were set to deliver closing arguments on Monday in the second trial over Merck & Co Inc.'s painkiller Vioxx, a case seen as key in determining the future of thousands of other pending lawsuits filed by users of the drug.

Continue to Legal final arguments in Vioxx trial on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz